Navigation Links
Biologicals Transfer Proposal between US and Indian Biotechnology

An agreement in principle to enable the smooth transfer of microorganisms and biological materials from the US to India is an encouraging sign for Indian bioscience. But slow implementation of the country’s broader biotech // goals, including India’s grandiose scheme to become the global hub of contract research and clinical trials, may threaten its goal of becoming a major player.

Discussions in mid-June between acting US deputy secretary of commerce David A. Sampson and an Indian delegation led by science minister Kapil Sibal led to the biologics transfer proposal. Under the plan, India’s Department of Biotechnology (DBT) would procure biological material from the American Type Tissue Collection (ATCC) and warrant against their misuse or subsequent acquisition by bioterrorists, with safeguards and export controls similar to those around nuclear technology. We are in the process of resolving this important issue. Although ATCC says its regulations for export and distribution of infectious agents did not change after 9/11 and that Indian Scientists have full access to the public database, researchers claim problems working with the US based repository. “ATCC is usually prompt, but if you ask for a type strain or a reference strain, they do not even respond,: says a senior scientists at the Institute for Microbial Technology in Chandigarh, which operates the Microbial Type Culture Collection, MTCC, India’s only such culture collection.

Industry scientists admit that they cannot document the source of many for the basic tools for making vaccines and drugs, a potential basis for challenging bioenergetics patents. One solution, says FICCI is to create a global bank that will compulsorily collect patent protected biological materials an offer these to industries at a nominal cost, clearly establishing ownership. Government reluctance to grant exclusivity of clinical trial data may also scare away companies, analysts say. And even if implemented su ccessfully, the $2.5 billion per year business model ironically built on high disease prevalence and a billion plus, genetically diverse and economically weak population has it critics.

Samit Brahmachari, director of the Institute of Genomics and Integrative biology in New Delhi, India could create a substantial fund for buying intellectual property rights from small and medium enterprises around the world and turn them into higher value products in collaboration with MNCs. Visalakshi’s study of 229 Indian biotech companies concludes that 20 years after setting up DBT, India still has no clear definition of biotech. “Everything from fermentation to aquaculture and sericulture to bio fertilizer is clubbed under biotech, resulting in sub critical funding,” India needs ‘to set priorities in the R&D work program,” it says, and should urgently address problem arising out of a large number of agencies dealing with biotech which has led to duplication of research funding and a lack of coordination.

Source: Nature Biotchnology.
'"/>




Related medicine news :

1. Free Tissue Transfer Effective in Treating Massive Skin Cancers
2. Tissue Transfer for Skin Cancer
3. Tissue Transfer For Treatment Of Massive Skin Cancers
4. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
5. Gene-Nanoparticle Gene Transfer Is Better Than Viral Vector Transfer System
6. Decreasing Multiple Births By Single Embryo Transfers
7. Therapeutic Genes Transferred By Viral Vector Through T Cell Masking
8. Punjabis Transfer Taste From Chicken To Prawns
9. Transplantation Results in CJD Transfer
10. Transfer of NHS hospital care into the community may not save costs
11. Mother Guilty of Transferring HIV to her Child
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... ... in the greater Dallas, Miami, and Raleigh regions, is organizing an extended charity ... a rare and deadly chromosome abnormality. , After struggling since birth with several ...
(Date:10/13/2017)... ... October 13, 2017 , ... The International ... promote standards of excellence for the field of eating disorders, announces the opening ... 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that covers care ... have a waiver for care if the client has a cognitive impairment diagnosis. ... for care, is often waived, so the benefits from their insurance start immediately,” said ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... will be giving viewers the lowdown on sciatica in a new episode of ... that focuses on current events and innovation and investigates each subject in-depth with ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)... Texas , Oct. 6, 2017   Provista, ... with more than $100 billion in purchasing power, today ... news and information. The Newsroom is the ... and industry trends, infographics, expert bios, news releases, slideshows ... having access to a wealth of resources at their ...
(Date:10/4/2017)... 2017  South Korean-based healthcare product Development Company I.M. ... on Kickstarter. The device will educate the user about ... better efficiency compared to the dated and pricey CPR ... efficacy of the compression for a more informed CPR ... to raise $5,000. ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
Breaking Medicine Technology: